Combinatorial liquid-phase synthesis of structurally diverse benzimidazole libraries

Journal of Combinatorial Chemistry

Volumn 2, Issue 4, 2000, Pages 341-348

  Yeh, Chih Ming ^a   Tung, Chieh Li ^a   Sun, Chung Ming ^a  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DESIGN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

BENZIMIDAZOLES; DRUG DESIGN; INDICATORS AND REAGENTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034218354     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc0000085     Document Type: Article

References (41)

1. (a) Gallop, M. A.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. J. Med. Chem. 1994, 37, 1233-1251.
2. (b) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449.
3. (c) Loughlin, W. A. Aust. J. Chem. 1998, 51, 875.
4. (a) Sherrington, D. C.; Hodge, P. In Synthesis and Separations Using Functional Polymers; John Wiley & Sons: New York, 1998.
5. (b) Früchtel, J. S.; Jung, G. Angew. Chem., Int. Ed. Engl. 1996, 35, 17.
6. (a) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1996, 52, 4527.
7. (b) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1997, 53, 5643.
8. (c) Booth, S.; Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1998, 54, 15385.
9. Leading papers in the LPCS study using PEG as a soluble support: (a) Han, H.; Wolfe, M.; Brenner, S.; Janda, K. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 6419.
10. (b) Park, W. C.; Auer, M.; Jaksche, H.; Wong, C. H. J. Am. Chem. Soc. 1996, 118, 10150.
11. (c) For a review, see: Gravert, D. J.; Janda, K. D. Chem. Rev. 1997, 97, 489.
12. (d) Dreef-Tromp, C. M.; Willems, H. A. M.; Westerduin, P.; van Veelen, P.; van Boeckel, C. A. A. Bioorg. Med. Chem. Lett. 1997, 7, 1175.
13. (e) Blettner, C. G.; König, W. A.; Stenzel, W.; Schotten, T. J. Org. Chem. 1999, 64, 3885.
14. Curran, D. P. Science (Washington, D. C.) 1997, 275, 823.
15. (a) Chen, S.; Janda, K. D. J. Am. Chem. Soc. 1997, 119, 8724.
16. (b) Chen, S.; Janda, K. D. Tetrahedron Lett. 1998, 39, 3943.
17. (a) Pan, P. C.; Sun, C. M. Tetrahedron Lett. 1998, 39, 9505.
18. (b) Shey, J. Y.; Sun, C. M. Synlett 1998, 12, 1423.
19. (c) Yeh, C. M.; Sun, C. M. Synlett 1999, 6, 810.
20. (d) Pan, P. C.; Sun, C. M. Bioorg. Med. Chem., Lett. 1999, 40, 1537.
21. (e) For a review, see: Sun, C. M. Comb. Chem., High Throughput Screening 1999, 2, 307.
22. Beck, J. P.; Arvanitis, A. G.; Curry, M. A.; Rescinito, J. T.; Fitzgerald, L. W.; Gilligan, P. J.; Zaczek, R.; Trainor, G. L. Bioorg. Med. Chem. Lett. 1999, 9, 967.
23. Cereda, E.; Turconi, M.; Ezhaya, A.; Bellora, E.; Brambilla, A.; Pagani, F.; Donetti, A. Eur. J. Med. Chem. 1987, 22, 527.
24. Al-Muhaimeed, H. Int. Med. Res. 1997, 25, 175.
25. Salluja, S.; Zou, R.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1996, 39, 881.
26. Zarrinmayeh, H.; Zimmerman, D. M.; Cantrell, B. E.; Schober, D. A.; Bruns, R. F.; Gackenheimer, S. L.; Ornstein, P. L.; Hipskind, P. A.; Britton, T. C.; Gehlert, D. R. Bioorg. Med. Chem. Lett. 1999, 9, 647.
27. While this manuscript was in preparation, a paper describing PEG-assisted synthesis of biaryl benzimidazoles by a different approach appeared: Blettner, C. G.; König, W. A.; Rühter, G.; Stenzel, W.; Schotten, T. Synlett 1999, 3, 309.
28. A preliminary communication was presented at the 17th International Congress of Heterocyclic Chemistry, Vienna, Austria, August 1-6 1999; PO-224. See also ref 7c.
29. (a) Dankwardt, S. M.; Newman, S. R.; Ksrtenansky, J. L. Tetrahedron Lett. 1995, 36, 4923.
30. (b) Shapiro, M. J.; Kumaravel, G.; Petter, R. C.; Beveridgr, R. Tetrahedron Lett. 1996, 37, 4671.
31. 3OH cleavage conditions to detach products for the purpose of analysis at the each of the synthetic sequence. After evaporation of solvent, the crude yields were calculated based on the initial loading of MeOPEG-OH (MW: 5000), and the crude products were regularly analyzed by HPLC and MS.
32. Morita, S.; Kitano, K.; Matsubara, J.; Ohtani, T.; Kawano, Y.; Otsubo, K.; Uchida, M. Tetrahedron 1998, 54, 4811.
33. (a) Meyers, H. V.; Dilley, G. J.; Durgin, T. L.; Powers, S. T.; Winsinger, N. A.; Zhu, H.; Pavia, M. R. Mol. Diversity 1995, 1, 13.
34. (b) Phillips, G. B.; Wei, G. B. Tetrahedron Lett. 1996, 37, 4887.
35. (a) Look, G. C.; Holmes, C. P.; Chinn, J. P.; Gallop, M. A. J. Org. Chem. 1994, 59, 7588.
36. (b) Johnson, C. R.; Zhang, B. Tetrahedron Lett. 1995, 36, 9253.
37. (c) Keifer, P. A. Drugs Future 1998, 23, 301.
38. (a) Fitch, W. L.; Detre, G.; Holmes, C. P.; Shoolery, J. N.; Keifer, P. A. J. Org. Chem. 1994, 59, 7955.
39. (b) Garigipati, R. S.: Adams, B.; Adams, J. L.; Sarkar, S. K. J. Org. Chem. 1996, 61, 2911.
40. (c) Chin, J.; Fell, B.; Pochapsky, S.; Shapiro, M.; Wareing, J. R. J. Org. Chem. 1998, 63, 1309.
41. Yan, B. Acc. Chem. Res. 1998, 31, 621.